CONCENTRATIONS |
3 Months Ended |
|---|---|
Mar. 31, 2022 | |
| Risks and Uncertainties [Abstract] | |
| CONCENTRATIONS |
NOTE L – CONCENTRATIONS The Company had no revenue for the three months ended March 31, 2022. Revenue from one licensee constituted 100% of the Company’s revenue of the three months ended March 31, 2021. At March 31, 2022 and December 31, 2021, the Company had no royalty receivables. |
| X | ||||||||||
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|